Empyrean Capital Partners’s Cardlytics CDLX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-201,780	Closed	-$2.95M	–	64
2018 Q1	$2.95M	Buy	+201,780	New	+$2.95M	0.16%	56